Top News

Santhera to Raise Capital Through Sale of Newly Created Shares

SBA Member News, 31.07.2015

Santhera Pharmaceuticals (SIX: SANN) announces the intent to sell up to 300,000 registered shares of newly created treasury shares (representing 6.03% of the company's total outstanding share capital). The proceeds will be used to finance the commercial launch of Raxone® in Leber's Hereditary Optic Neuropathy (LHON) in Europe.


Next Event


Community Login

Bachem Holding AG